Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04373785
Title NG101m Adjuvant Therapy in Glioblastoma Patients
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NeuGATE Theranostics
Indications

glioblastoma

Therapies

NG101m + Temozolomide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.